Journal of Drugs in Dermatology

View more issues:

Articles in Nov-Dec, 2005 issue of Journal of Drugs in Dermatology

• Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation
  by Stuart Melnick
• COL-3 demonstrates promising results for treating rosacea
• Bioengineered skin and wound healing
• Etanercept for treatment of hidradenitis
• Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin
  by Kristin Ziel
• Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study
• Phase I study of Staphylococcus aureus Type 336 vaccine
• Study to determine the safety of two applications of PEP005 topical gel to nodular basal cell carcinoma
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects
  by John Starling, III
• Treatment of erythematotelangiectactic rosacea with a KTP YAG laser
  by Amy Miller
• Synera topical anesthesia approved by FDA
• Survivin peptide vaccination for patients with advanced melanoma, pancreatic, colon and cervical cancer
• Prophylaxis for and treatment of uncomplicated skin and skin structure infections in laser and cosmetic surgery
  by Mark S. Nestor
• Aczone approved for acne
• Open-label assessment of the efficacy & safety of efalizumab in the treatment of mod-severe hidradenitis suppurativa
• Study of ONTAK in previously treated Cutaneous T-cell Lymphoma patients
• Safety and efficacy of alefacept in elderly patients and other special populations
  by Alice B. Gottlieb
• Q-switched Alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring
  by Antonio Rusciani
• Schools of Pharmacology
  by Noah Scheinfeld
• To study the effects of CD25 and low dose Cyclosporin in the treatment of active psoriasis vulgaris
• Perioperative use of antibiotics: preventing and treating perioperative infections
  by Mark S. Nestor
• Imiquimod as an antiangiogenic agent
  by Vincent W. Li
• Trichophyton tonsurans associated tinea corporis infection with the development of Majocchi's granuloma in a renal transplant patient
  by Vidya Rajpara
• Metronidazole 1% Topical Gel approved for rosacea
• Topical NF-kappa B Decoy in the treatment of atopic dermatitis
• Treatment of uncomplicated skin and skin infections in the pediatric and adolescent patient populations
  by Lawrence A. Schachner
• A letter from the Editor-in-Chief
  by Perry Robins
• Tolerance to calcitriol and tacalcitol in three patients with allergic contact dermatitis to calcipotriol
  by Foti Caterina
• FDA approves generic Ultravate
• Generic Locoid approved by FDA
• Five-year safety study of pimecrolimus cream 1% in infants 3 to less than 12 months of age with mild to moderate atopic dermatitis
• Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm
  by Dirk M. Elston
• Elidel-study
• Generic Allegra 60 mg gains FDA approval
• Pimecrolimus Cream 1% plus topical corticosteroid in patients with severe atopic dermatitis
• The effect of Efudex treatment on photoaged skin
• CollaGenex files New Drug Application for Oracea
• Temozolomide vs. dacarbazine in stage IV metastatic melanoma
• Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data
  by Rajesh Balkrishnan
• Orlando Dermatology & Aesthetic Conference
• Avelox IV approved for complicated skin and skin structure infections
• Treatment of uncomplicated skin and skin structure infections in the diabetic patient
  by Phoebe Rich
• Puerto Rico psoriasis study group: efficacy and safety of etanercept
  by Jose R. Gonzalez-Chavez
• Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging
• Imatinib in dermatofibrosarcoma protuberans
• Utilization of narrow band ultraviolet B light therapy and etanercept for the treatment of psoriasis
• Nodular melanoma: how current approaches to early detection are failing
  by John W. Kelly
• Dermatofibrosarcoma protuberans following tanning bed use
  by Daniel S. Behroozan
• A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo
• FDA approves iPLEDGE for isotretinoin
• Efficacy of Elidel cream on erosive oral lichen planus
• Update on treating uncomplicated skin and skin structure infections
  by Theodore Rosen
• ABthrax Phase I clinical trial promising
• MediGene announces Phase 2 trial results of Polyphenon E for treatment of actinic keratosis
• Hydroxychloroquine vs. clobetasol rinse to treat oral lichen planus
• A study of the use of methotrexate in the treatment of chronic idiopathic urticaria
• Anti-CD20 monoclonal antibody in the treatment of pemphigus
• Introduction
• Bullous pemphigoid following therapy with an oral beta-blocker
  by Adam Perry
• The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: a randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle
• Early topical nail fungus treatment promising
• Study to determine the safety of two applications of PEP005 topical gel to superficial basal cell carcinoma
• Study of ONTAK in cutaneous T-cell lymphoma patients
• Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus
  by Thomas R. Fritsche